Back to Search Start Over

The ICER review is in: hope amidst uncertainty.

Authors :
Begolka WS
Butler L
Guadalupe M
Source :
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2022 Jan; Vol. 28 (1), pp. 115-118.
Publication Year :
2022

Abstract

DISCLOSURES: No funding contributed to the writing of this commentary. Smith Begolka, Butler, and Guadalupe are salaried employees of the National Eczema Association, which has received grants and sponsorship awards from a variety of industry partners, including AbbVie, Eli Lilly, Incyte, LEO Pharma, Pfizer, Regeneron, and Sanofi. Smith Begolka has received grant funding from Pfizer and advisory board honoraria from Pfizer and Incyte. Butler and Guadalupe have received advisory board honoraria from Incyte.

Details

Language :
English
ISSN :
2376-1032
Volume :
28
Issue :
1
Database :
MEDLINE
Journal :
Journal of managed care & specialty pharmacy
Publication Type :
Academic Journal
Accession number :
34949117
Full Text :
https://doi.org/10.18553/jmcp.2022.28.1.115